A nurse is caring for a client who has spinal stenosis. Which of the following conditions should the nurse recognize as a risk factor for spinal stenosis?

Choice A Reason:

Chronic obstructive pulmonary disease (COPD) is inappropriate.COPD is a chronic lung disease characterized by airflow limitation. While COPD does not directly cause spinal stenosis, some individuals with COPD may have comorbidities or risk factors, such as osteoporosis or degenerative changes in the spine, which can contribute to spinal stenosis.

Choice B Reason:

Laminectomy is appropriate. A laminectomy is a surgical procedure used to decompress the spinal cord or nerves by removing the lamina (back part of the vertebra). While a laminectomy can be a treatment option for spinal stenosis, it is not a risk factor for developing the condition.

Choice C Reason:

Hysterectomy is inappropriate. Hysterectomy, the surgical removal of the uterus, is not directly associated with spinal stenosis. However, certain conditions or factors leading to a hysterectomy, such as pelvic tumors or endometriosis, may indirectly contribute to spinal stenosis if they cause changes in the spine or affect posture.

Choice D Reason:

Hyperthyroidism is appropriate. Hyperthyroidism, a condition characterized by excessive production of thyroid hormones, is not a known risk factor for spinal stenosis.

Choice A Reason:

Dulaglutide is inappropriate. Dulaglutide is a medication used to treat type 2 diabetes by improving blood sugar control. It is not indicated for the management of neurogenic bladder or urinary incontinence.

Choice B Reason:

Montelukast sodium is inappropriate. Montelukast sodium is a medication primarily used to treat asthma and allergic rhinitis by blocking leukotrienes, which are inflammatory substances that contribute to asthma and allergy symptoms. It is not indicated for the management of neurogenic bladder or urinary incontinence.

Choice C Reason:

Glatiramer acetate is inappropriate. Glatiramer acetate is a medication used to treat relapsing-remitting multiple sclerosis (MS) by modulating the immune system. It is not indicated for the management of neurogenic bladder or urinary incontinence.

Choice D Reason:

Oxybutynin is appropriate. Oxybutynin is a medication commonly prescribed for the management of neurogenic bladder and urinary incontinence. It belongs to a class of medications called anticholinergics, which work by relaxing the bladder muscles and reducing bladder spasms. Oxybutynin helps control urinary urgency, frequency, and incontinence associated with neurogenic bladder, including spasm-induced incontinence.